DOP2004000966A - 6 MEMBER HETEROARILE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS - Google Patents

6 MEMBER HETEROARILE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

Info

Publication number
DOP2004000966A
DOP2004000966A DO2004000966A DO2004000966A DOP2004000966A DO P2004000966 A DOP2004000966 A DO P2004000966A DO 2004000966 A DO2004000966 A DO 2004000966A DO 2004000966 A DO2004000966 A DO 2004000966A DO P2004000966 A DOP2004000966 A DO P2004000966A
Authority
DO
Dominican Republic
Prior art keywords
compounds
heteroarile
treatment
neurodegenerative disorders
formula
Prior art date
Application number
DO2004000966A
Other languages
Spanish (es)
Inventor
Yuhpyng Liang Chen
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to DO2004000966A priority Critical patent/DOP2004000966A/en
Publication of DOP2004000966A publication Critical patent/DOP2004000966A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invencion se refiere a compuestos de la Formula en donde R1, R1a, R1b, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, X, Y, W, U, Z, m y n son como se los define. Compuestos de la Formula I presentan actividad inhibidora de la produccion de peptido Ap. Esta invencion se refiere ademàs a composiciones farmaceuticas y metodos para tratar enfermedades, por ejemplo, enfermedades neurodegenerativas, i.e. enfermedad de Alzheimer, en un mamifero, que comprenden compuestos de la Formula I.The present invention relates to compounds of the Formula wherein R1, R1a, R1b, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, X, Y, W, U, Z, Myn are as defined. Compounds of Formula I exhibit inhibitory activity of peptide production Ap. This invention also relates to pharmaceutical compositions and methods for treating diseases, for example, neurodegenerative diseases, i.e. Alzheimer's disease, in a mammal, comprising compounds of Formula I.

DO2004000966A 2004-08-02 2004-08-02 6 MEMBER HETEROARILE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS DOP2004000966A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2004000966A DOP2004000966A (en) 2004-08-02 2004-08-02 6 MEMBER HETEROARILE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2004000966A DOP2004000966A (en) 2004-08-02 2004-08-02 6 MEMBER HETEROARILE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

Publications (1)

Publication Number Publication Date
DOP2004000966A true DOP2004000966A (en) 2005-02-15

Family

ID=44261387

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2004000966A DOP2004000966A (en) 2004-08-02 2004-08-02 6 MEMBER HETEROARILE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

Country Status (1)

Country Link
DO (1) DOP2004000966A (en)

Similar Documents

Publication Publication Date Title
UY28450A1 (en) 6 MEMBER HETEROARILE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS.
PA8627201A1 (en) IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
CR7785A (en) TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
DOP2005000049A (en) SULFONAMID COMPOUNDS FOR THE TREATMENT OF NEURODEGERERATIVE DISORDERS
UY28484A1 (en) COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
UY30377A1 (en) FUSIONATED TRICYCLE INHIBITORS OF SULFONAMIDE OF GAMA-SECRETASA
DOP2004000888A (en) BENZAMIDA 2-HYDROXI-3-DIAMINOALCANS (BENZAMIDE 2-HYDROXY-3-DIAMINOALKANES
ECSP088593A (en) 5- (ARILSULFONIL) -PIRAZOLOPIPERIDINS
UY27872A1 (en) CASPASA INHIBITORS AND USES OF THE SAME.
UY28333A1 (en) CASPASA INHIBITORS AND THEIR USES.
ATE534736T1 (en) IDENTIFICATION METHODS AND COMPOUNDS FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
BRPI0409721A (en) isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders
CR9815A (en) IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
BRPI0509559A (en) pyrazolamine compounds for the treatment of neurodegenerative disorders
BR0306855A (en) Method for the treatment of cognitive disorders
UY28458A1 (en) OXAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
CR11436A (en) MODULATORS LINKED TO AMIDA Y-SECRETASA
UY32002A (en) GAMMA-SECRETASA PIRIDINYL MODULATORS
DOP2004000966A (en) 6 MEMBER HETEROARILE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
BRPI0509881A (en) therapeutic combination for treatment of alzheimer's disease
DOP2004000970A (en) OXAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
NI201000066A (en) AMINES ATTACHED TO THE y-SECRETASE MODULATORS.
DOP2004000982A (en) COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
DOP2006000200A (en) IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL TRANSFERS
CU23591B7 (en) IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEUROVEGETATIVE DISORDERS